Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2011.0166
NEWS & VIEWS
|
Genotyping vs. exome sequencing for cancer. |
|
Affiliation: Dr. John Spiliotis, Head of Department of Surgery, "METAXA" Cancer Memorial Hospital, Botosi 51, TK 18535, Piraeus, Greece.
E-mail: jspil@in.gr |
Since there is no abstract available we provide the first paragraph.
The advent of next-generation sequencing (NGS) with the powerful unprecedented ability for the whole genome scan or exome sequencing ?sequence of all the coding regions of our genome- allows the unbiased identification of mutations involved in various cancer types [1-5]. Traditional genotyping of individual genes has also been widely evaluated and may provide useful information for the clinic. A recent example of gastric cancer genotyping has been recently published [6]. Here it is evaluated the potential utility and challenges of traditional genotyping. Best Replica Watches
(Citation: Gastric & Breast Cancer 2011; 10(2):
103-105)
|
|
| You can have an online full-text access and a PDF of this article: |
- Either purchase this paper for €33 EUR. Please, click here
|
|
- Or through one year subscription PayPal
|
|
Online
ISSN : 1109 - 7647
Print ISSN : 1109 - 7655
 We
subscribe to the HONcode principles. Verify
here.
please, read our policy about privacy
and confidentiality of information and transparency
of sponsorship
last
update: 16 March 2011 |
|
